Related Experiment Video
Updated: Mar 16, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders
Anna Lecchi, Eti A Femia, Silvia Paoletta
1Katharina Machura, University Medical Center, Freiburg - Department of Pediatrics and Adolescent Medicine, Breisacher-Str. 66, 79106 Freiburg, Germany, Tel. +49/(0)761/27 06 37 10,
A novel mutation in the P2Y12 receptor gene causes lifelong bleeding disorders. This His187Gln substitution impairs ADP-promoted platelet aggregation by reducing ligand-receptor affinity.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- The P2Y12 receptor (P2Y12R) is crucial for platelet aggregation.
- Dysfunctional P2Y12R mutations can lead to congenital lifelong bleeding disorders.
Purpose of the Study:
- To report a newly identified dysfunctional P2Y12R variant in patients with severe bleeding disorders.
- To characterize the molecular and functional consequences of this mutation.
Main Methods:
- Genetic sequencing to identify mutations in the P2Y12R gene.
- In vitro platelet aggregation studies to assess ADP-promoted aggregation.
- Structure modeling to predict the impact of the mutation on receptor function.
Main Results:
- A homozygous c.561T>A substitution (p.His187Gln) was identified in two brothers with severe bleeding.
- Patient platelets exhibited reduced and rapidly reversible ADP-promoted aggregation.
- The p.His187Gln mutation decreased ligand affinity without altering receptor expression.
- Structure modeling indicated impaired conformational changes in the TM5 domain.
Conclusions:
- The p.His187Gln mutation in P2Y12R causes a severe bleeding disorder.
- Impaired receptor function is due to reduced ligand affinity and altered receptor conformation.
- The TM5 region is essential for P2Y12R agonist/antagonist binding and overall function.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

